Jennifer Ellen Miller, PhD
Associate Professor of Medicine (General Medicine); Director, Good Pharma Scorecard; Board President, Bioethics International; Advisory Board Member, Global Healthcare Innovation Management Center, Graduate School of Business; Yale Liaison, Working Group on: Bioethics of Data Science, Artificial Intelligence (AI) and Genomics Implementation Science Curriculum; Expanded Access Program for Experimental Covid19 Drugs, Ethics Committee
Biography
Research & Publications
News
Appointments
Biography
Jennifer E. Miller, PhD, is an Associate Professor in Yale School of Medicine; Director of the Good Pharma Scorecard (an index that ranks pharmaceutical companies on their bioethical performance); and Founder of the nonprofit Bioethics International.
Her current research focuses on ethics, equity and governance in drug, vaccine and medical device research, development, and delivery as well as in healthcare data sharing. She also specializes in developing and using metrics to enhance accountability and social responsibility in biomedical innovation.
Prior to joining Yale’s faculty, she was an Assistant Professor (tenure track) in NYU School of Medicine and completed training in physics, regulatory governance, bioethics, and ethics at Fordham University, Duke University, Regina Apostolorum Pontifical University, and Harvard University.
Education & Training
- Non Degree ProgramHarvard University, Ethics (2015)
- Postdoctoral FellowshipDuke University (2015)
- PhDRegina Apostolorum Pontifical University, Bioethics (2015)
- Postdoctoral FellowshipHarvard University (2014)
- BSFordham University, Physics (2002)
Activities
- Pharmaceutical Industry Ethics and The Good Pharma ScorecardNew York, NY, United States 2020Pharmaceutical Industry Ethics and The Good Pharma Scorecard
- What Makes Medical Data Sharing Ethical?New York, NY, United States 2020What Makes Medical Data Sharing Ethical?
- Clinical Trial Transparency and Data SharingBroadstairs, England, United Kingdom 2020Clinical Trial Transparency and Data Sharing
- Panel on Genomic Medicine EthicsSan Diego, CA, United States 2020Panel on Genomic Medicine Ethics
- EHR Data Sharing: What Makes Data Sharing Ethical?Philadelphia, PA, United States 2020EHR Data Sharing: What Makes Data Sharing Ethical?
- Transparency and Data Sharing in Clinical Trials: Ethics Standards and the Role of the Good Pharma ScorecardOttawa, ON, Canada 2020Transparency and Data Sharing in Clinical Trials: Ethics Standards and the Role of the Good Pharma Scorecard
- Bioethics and Controversial Trends in Healthcare InnovationNew York, NY, United States 2020Bioethics and Controversial Trends in Healthcare Innovation
- Responsible Data Sharing in Medicine and Clinical ResearchMontreal, QC, Canada 2020Responsible Data Sharing in Medicine and Clinical Research
- Non-Trial Preapproval Access to Investigational Medical ProductsNew York, NY, United States 2020Non-Trial Preapproval Access to Investigational Medical Products
- Discuss Ethical Standards for Clinical Research and the Responsibilities of the Life Sciences IndustryCoral Gables, FL, United States 2020Discuss Ethical Standards for Clinical Research and the Responsibilities of the Life Sciences Industry
- Oral PresentationPhiladelphia, PA, United States 2020Oral Presentation
- Global Health Justice and Access to MedicinesBinghamton, NY, United States 2020Global Health Justice and Access to Medicines
- Transparency in Health and Healthcare in the United States, Panel Presentation: Transparency and Data sharing in the Pharmaceutical IndustryCambridge, MA, United States 2019Transparency in Health and Healthcare in the United States, Panel Presentation: Transparency and Data sharing in the Pharmaceutical Industry
- Ethics of Clinical Trials and Data PrivacyJerusalem, Jerusalem District, Israel 2019Ethics of Clinical Trials and Data Privacy
- Access to Emerging Therapies for Genetic DisordersRochester, NY, United States 2019Access to Emerging Therapies for Genetic Disorders
- Responsible Clinical Trial Transparency and Data SharingPhiladelphia, PA, United States 2019Responsible Clinical Trial Transparency and Data Sharing
- Responsible Data SharingPhiladelphia, PA, United States 2019Responsible Data Sharing
- Brain Health and Performance Summit, Whose Data are They?Columbus, OH, United States 2019Brain Health and Performance Summit, Whose Data are They?
- Inaugural Councils MeetingSan Francisco, CA, United States 2019Inaugural Councils Meeting
- Progress Towards the Sustainable Development GoalsPrinceton, NJ, United States 2019Progress Towards the Sustainable Development Goals
- Ethics of Data-Sharing in Digital MedicineBoston, MA, United States 2019Ethics of Data-Sharing in Digital Medicine
- Roundtable on Data-Sharing in MedicineLos Angeles, CA, United States 2019Roundtable on Data-Sharing in Medicine
- Ethics of Big Data and AI in RadiologyNew York, NY, United States 2019Ethics of Big Data and AI in Radiology
- Social Responsibility in PharmaPhiladelphia, PA, United States 2019Social Responsibility in Pharma
- Breaking Barriers to Health Data GovernanceSan Francisco, CA, United States 2019Breaking Barriers to Health Data Governance
- Ethics of Federated ModelsSan Francisco, CA, United States 2019Ethics of Federated Models
- Solutions Approach to Data Privacy and EthicsWashington, DC, United States 2019Solutions Approach to Data Privacy and Ethics
- Establishing a Pharma Code of EthicsBarcelona, CT, Spain 2019Establishing a Pharma Code of Ethics
- Preventing the Cambridge Analytica of Health DataAustin, TX, United States 2019Preventing the Cambridge Analytica of Health Data
- Data-sharing Principles in MedicineBethesda, MD, United States 2019Data-sharing Principles in Medicine
- Ethics of Emerging BiotechnologiesDubai, Dubai, United Arab Emirates 2018Ethics of Emerging Biotechnologies
- The Ethics of Big Data in Healthcare. October 24, 2018New York, NY, United States 2018Opening Keynote: The Ethics of Big Data in Healthcare. October 24, 2018
- The Future of Health Summit, Panel on InnovationLos Angeles, CA, United States 2018The Future of Health Summit, Panel on Innovation
- Measuring Impact in Patient-Centered Drug DevelopmentBethesda, MD, United States 2018Measuring Impact in Patient-Centered Drug Development
- Blockchain as Pharma's Trust CatalystMadrid, Community of Madrid, Spain 2018Blockchain as Pharma's Trust Catalyst
- Deconstructing Clinical Trials: The Core of Drug Development and Company ValuationsLondon, England, United Kingdom 2018Deconstructing Clinical Trials: The Core of Drug Development and Company Valuations
- Ethics and Trust in Healthcare InnovationNew York, NY, United States 2018Keynote, Ethics and Trust in Healthcare Innovation
- Research Ethics WorkshopNew York, NY, United States 2018Research Ethics Workshop
- Promise and Reality of Clinical Trial Transparency and Data-sharingLondon, England, United Kingdom 2018Promise and Reality of Clinical Trial Transparency and Data-sharing
- Ethics and Governance and Healthcare InnovationNew York, NY, United States 2018Ethics and Governance and Healthcare Innovation
- Clinical Trial Transparency and Data-sharing in Healthcare InnovationNew York, NY, United States 2018Clinical Trial Transparency and Data-sharing in Healthcare Innovation
- Drug Accessibility and Pricing Symposium: Preserving Consumer Access in the Complex Pharmaceuticals MarketplaceBaltimore, MD, United States 2018Drug Accessibility and Pricing Symposium: Preserving Consumer Access in the Complex Pharmaceuticals Marketplace
- Big Data and EthicsNew York, NY, United States 2018Big Data and Ethics
- Ethics of Big Data, Machine Learning and AINew York, NY, United States 2018Ethics of Big Data, Machine Learning and AI
- Elevate Organizational and New Drug Clinical Trial Transparency Best PracticesPhiladelphia, PA, United States 2018Elevate Organizational and New Drug Clinical Trial Transparency Best Practices
- Lecture on Pharmaceutical EthicsAugusta, GA, United States 2017Lecture on Pharmaceutical Ethics
- Ethics, Transparency and Trust in Pharma and the Role of the Good Pharma ScorecardAugusta, GA, United States 2017Ethics, Transparency and Trust in Pharma and the Role of the Good Pharma Scorecard
- Augmented Humans: Are Super Humans the New Reality?Dubai, Dubai, United Arab Emirates 2017Augmented Humans: Are Super Humans the New Reality?
- Cybersecurity’s Accelerating Threat: The Impact of Evolving TechnologiesNew York, NY, United States 2017Cybersecurity’s Accelerating Threat: The Impact of Evolving Technologies
- Returning Lay Summaries to Trial ParticipantsPhiladelphia, PA, United States 2017Returning Lay Summaries to Trial Participants
- Data-Sharing: Do We Measure Up?Rockville, MD, United States 2017Data-Sharing: Do We Measure Up?
- The Need to Accelerate Therapeutic Development — Must Randomized Controlled Trials Give Way?New York, NY, United States 2017The Need to Accelerate Therapeutic Development — Must Randomized Controlled Trials Give Way?
- Transparency in HealthcareCambridge, MA, United States 2017Transparency in Healthcare
- The Intersecting Worlds of Researchers, Executives and JournalistsGreencastle, IN, United States 2017The Intersecting Worlds of Researchers, Executives and Journalists
- Ethics and Trust in the Pharmaceutical IndustryNew York, NY, United States 2017Ethics and Trust in the Pharmaceutical Industry
- Cyber SecurityNew York, NY, United States 2017Cyber Security
- Clinical Trial Transparency, Data-sharing, and the Good Pharma ScorecardNew Brunswick, NJ, United States 2017Clinical Trial Transparency, Data-sharing, and the Good Pharma Scorecard
- Healthcare Innovation EthicsNew York, NY, United States 2017Healthcare Innovation Ethics
- Clinical Data Disclosure and Transparency: Navigate Global Regulations, Data Sharing and Trial Registries, Explore Ethics and The Good Pharma ScorecardLondon, England, United Kingdom 2017Clinical Data Disclosure and Transparency: Navigate Global Regulations, Data Sharing and Trial Registries, Explore Ethics and The Good Pharma Scorecard
- Access, Value, and Trust in Healthcare InnovationNewport Beach, CA, United States 2017Access, Value, and Trust in Healthcare Innovation
- Clinical Trial Transparency, Drug Development, and the Good Pharma ScorecardNew York, NY, United States 2016Clinical Trial Transparency, Drug Development, and the Good Pharma Scorecard
- Clinical Trial Data Sharing: Status & Benchmarking—Good Pharma ScorecardBasel, BS, Switzerland 2016Clinical Trial Transparency and Regulation Conference, Clinical Trial Data Sharing: Status & Benchmarking—Good Pharma Scorecard
- Ethics and Trust in Healthcare InnovationPalo Alto, CA, United States 2016Ethics and Trust in Healthcare Innovation
- Workshop on Ethical Issues in Marketing Pharmaceuticals in Emerging Health SystemsNewark, NJ, United States 2016Workshop on Ethical Issues in Marketing Pharmaceuticals in Emerging Health Systems
- Working Together to Serve PatientsNew York, NY, United States 2016Working Together to Serve Patients
- Caring for Vulnerable Populations: Cognitive Assessment, Ethical Considerations, and Health PolicyNew York, NY, United States 2016Caring for Vulnerable Populations: Cognitive Assessment, Ethical Considerations, and Health Policy
- Ethics and Transparency in Healthcare InnovationPhiladelphia, PA, United States 2016Ethics and Transparency in Healthcare Innovation
- The Good Pharma Scorecard: Special Focus on PublicationsTarrytown, NY, United States 2016The Good Pharma Scorecard: Special Focus on Publications
- Ethical Issues in Clinical ResearchNew York, NY, United States 2016Ethical Issues in Clinical Research
- Pharmaceutical Strategy: Ethics and Reputational HazardsNew York, NY, United States 2016Pharmaceutical Strategy: Ethics and Reputational Hazards
- Ethics and Governance of Healthcare Innovation and the Good Pharma ScorecardNew York, NY, United States 2016Ethics and Governance of Healthcare Innovation and the Good Pharma Scorecard
- Critical Issues in Emergency Medicine Antidotes in Society: Ethics, Capital, Regulation, Scientific Principle, Public Health, and the Public GoodNew York, NY, United States 2016Critical Issues in Emergency Medicine Antidotes in Society: Ethics, Capital, Regulation, Scientific Principle, Public Health, and the Public Good
- Institutional Corruption in Medicine and Healthcare Innovation: Concerns, Benchmarks, and a Roadmap for Trustworthy ReformWashington, DC, United States 2016Institutional Corruption and Medicine
- Institutional Corruption and MedicineChattanooga, TN, United States 2016Institutional Corruption and Medicine
- Clinical trial registration, reporting, publication and FDAAA compliance: a cross-sectional analysis and ranking of new drugs approved by the FDA in 2012New York, NY, United States 2015Clinical trial registration, reporting, publication and FDAAA compliance: a cross-sectional analysis and ranking of new drugs approved by the FDA in 2012
- LectureNew York, NY, United States 2015Lecture
- Research Spotlight PresentationNew York, NY, United States 2015Research Spotlight Presentation
- Ethics and Trust in Healthcare Innovation: Could Ranking Pharmaceutical Companies and New Drugs on Clinical Trial Transparency Help?Baltimore, MD, United States 2015Ethics and Trust in Healthcare Innovation: Could Ranking Pharmaceutical Companies and New Drugs on Clinical Trial Transparency Help?
- Transparency and Data Sharing RoundtableCambridge, MA, United States 2015Transparency and Data Sharing Roundtable
- Promises and Pitfalls of our Clinical Research SystemNew York, NY, United States 2015Lecture
- The Ethics of Healthcare InnovationNew York, NY, United States 2015The Ethics of Healthcare Innovation
- LectureLondon, England, United Kingdom 2015Lecture
- LectureBinghamton, NY, United States 2015Lecture
- Institutional Corruption in MedicineCambridge, MA, United States 2015Institutional Corruption in Medicine
- Research EthicsNew York, NY, United States 2015Research Ethics
- Ethics, Trust, Global Health and the Pharmaceutical IndustryCambridge, MA, United States 2015Ethics, Trust, Global Health and the Pharmaceutical Industry
- LectureBinghamton, NY, United States 2015Lecture
- Bioethics and Trust in the Industry– Could Rating Help?Cambridge, MA, United States 2015Bioethics and Trust in the Industry– Could Rating Help?
- Ethics, Trust, Global Health and the Pharmaceutical IndustryDurham, NC, United States 2015Ethics, Trust, Global Health and the Pharmaceutical Industry
- Shining Light on Healthcare InnovationDurham, NC, United States 2015Shining Light on Healthcare Innovation
- Data-sharing in Clinical TrialsCambridge, MA, United States 2015Data-sharing in Clinical Trials
- Combatting Institutional Corruption in Medicine with the Open Pharma IndexCambridge, MA, United States 2015Institutional Corruption in Medicine
- Ethics, Human Rights and the Pharmaceutical IndustryDurham, CT, United States 2015Ethics, Human Rights and Business
- Transparency and Ethics in Healthcare InnovationNewark, NJ, United States 2015Transparency and Ethics in Healthcare Innovation
- Compassionate Use and Pre-Approval Access to Experimental DrugsNew York, NY, United States 2015Compassionate Use and Pre-Approval Access to Experimental Drugs
- Ethics, Human Rights and the Pharmaceutical IndustryDurham, NC, United States 2015Ethics, Human Rights and the Pharmaceutical Industry
- Transparency and Ethics in Healthcare InnovationNewark, NJ, United States 2015Transparency and Ethics in Healthcare Innovation
- Corruption, Ethics and Governance in Biomedical ResearchDurham, NC, United States 2014Corruption, Ethics and Governance in Biomedical Research
- Adaptive Regulatory Strategies in Healthcare InnovationDurham, NC, United States 2014Adaptive Regulatory Strategies in Healthcare Innovation
- Transparency and Trust in the Pharmaceutical Industry: Could Rating Help?Cambridge, MA, United States 2014Transparency and Trust in the Pharmaceutical Industry: Could Rating Help?
- Ethics in the Pharmaceutical Industry: Could Rating Help?New York, NY, United States 2014Ethics in the Pharmaceutical Industry: Could Rating Help?
- Bioethics and Trust in the Industry– Could Rating Help?Cambridge, MA, United States 2014Bioethics and Trust in the Industry– Could Rating Help?
- Ethics and Trust in the Pharmaceutical IndustryMexico City, CDMX, Mexico 2014Ethics and Trust in the Pharmaceutical Industry
- Truth-telling and the Pharmaceutical IndustryNew York, NY, United States 2014Truth-telling and the Pharmaceutical Industry
- Institutional Corruption in Big PharmaCambridge, MA, United States 2014Institutional Corruption in Big Pharma
- Pharmaceutical Ethics: Industry Perspectives and a Strategy for Trustworthy ReformCambridge, MA, United States 2014Pharmaceutical Ethics: Industry Perspectives and a Strategy for Trustworthy Reform
- Ethical Standards in the Pharmaceutical Industry? Problems and a Strategy for Trustworthy ReformPittsburgh, PA, United States 2014Ethical standards in the Pharmaceutical Industry? Problems and a Strategy for Trustworthy Reform
- Companies’ Global Health Footprint: Could Rating Help?Cambridge, MA, United States 2013Companies’ Global Health Footprint: Could Rating Help?
- Globalization and the MarketNew York, NY, United States 2013Globalization and the Market
- Public Health EthicsWashington, DC, United States 2013Public Health Ethics
- Bioethics and Trust in the IndustryCambridge, MA, United States 2013Bioethics and Trust in the Industry
- Bioethics and Trust in the IndustryCambridge, MA, United States 2013Bioethics and Trust in the Industry
- Ethical Standards in the Pharmaceutical Industry?New York, NY, United States 2013Ethical Standards in the Pharmaceutical Industry?
- Institutional Corruption and Health Care: Ethical Standards in the Pharmaceutical Industry? Concerns, Industry Perspectives, and a Strategy for Trustworthy ReformAmherst, MA, United States 2013Institutional Corruption and Health Care: Ethical Standards in the Pharmaceutical Industry? Concerns, Industry Perspectives, and a Strategy for Trustworthy Reform
- Blinding Science: Blinding as a Solution to Institutional CorruptionCambridge, MA, United States 2013Blinding Science: Blinding as a Solution to Institutional Corruption
- Institutional Corruption and Health Care: Ethical Standards in the Pharmaceutical Industry? Concerns, Industry Perspectives, and a Strategy for Trustworthy ReformBoston, MA, United States 2013Power, Privilege and the Pursuit of Justice: Legal Challenges in Precarious Times
- Power, Privilege and the Pursuit of Justice: Legal Challenges in Precarious TimesBoston, MA, United States 2013Power, Privilege and the Pursuit of Justice: Legal Challenges in Precarious Times
- Ethical Standards in the Pharmaceutical Industry? Industry Perspectives and Reform StrategiesCambridge, MA, United States 2012Ethical Standards in the Pharmaceutical Industry? Industry Perspectives and Reform Strategies
- Pharmaceutical EthicsNew York, NY, United States 2012Pharmaceutical Ethics
- The Ethics of Drug Development and MarketingNew York, NY, United States 2012The Ethics of Drug Development and Marketing
- Ethical Standards for the Pharmaceutical Industry?Jersey City, NJ, United States 2012Ethical Standards for the Pharmaceutical Industry?
- Why Corruption is Harder to Resolve Than You Think: Lessons from the Politics of Regulatory RegimesNew Orleans, LA, United States 2012Why Corruption is Harder to Resolve Than You Think: Lessons from the Politics of Regulatory Regimes, January 14, 2012
- The Role of Virtue in Medicine,Chicago, IL, United States 2011The Role of Virtue in Medicine,
- Ethical Issues in Pediatric Emergency Mass Critical CareBangkok, Bangkok, Thailand 2011Ethical Issues in Pediatric Emergency Mass Critical Care
- Introduction to Bioethical FrameworksBangkok, Bangkok, Thailand 2011Introduction to Bioethical Frameworks
- Bioethical Issues in the Globalization of Clinical ResearchAlbany, NY, United States 2011Bioethical Issues in the Globalization of Clinical Research
- Pharmaceutical EthicsDurham, NC, United States 2011Pharmaceutical Ethics
- Genomics, Ethics and Industry PracticeBurnaby, BC, Canada 2011Genomics, Ethics and Industry Practice
- Medical Diplomacy: Response to Environmental DisastersNew York, NY, United States 2011Medical Diplomacy: Response to Environmental Disasters
- Ethical Concerns in Biotechnology and Health Care AdvancesWashington, DC, United States 2011Ethical Concerns in Biotechnology and Health Care Advances
- Next Steps for the Princeton University Open Hearts InitiativeNew Orleans, LA, United States 2011Next Steps for the Princeton University Open Hearts Initiative
- Disaster MedicineNew York, NY, United States 2010Disaster Medicine
- 15-year Review of the Implementation of the Beijing Declaration and Platform for Action (1995) and the Outcomes of the Twenty-Third Special Session of the General Assembly (2000)New York, NY, United States 201015-year Review of the Implementation of the Beijing Declaration and Platform for Action (1995) and the Outcomes of the Twenty-third Special Session of the General Assembly (2000)
- LectureTampa, FL, United States 2010Lecture
- LectureErie, PA, United States 2010Lecture
- Finding Common GroundPrinceton, NJ, United States 2010Debate
- Is Common Ground Possible?Princeton, NJ, United States 2010Is Common Ground Possible?
- Who Should be Responsible for Tomorrow’s Drugs?San Diego, CA, United States 2010Who Should be Responsible for Tomorrow’s Drugs?
- Introduction to Ethical Frameworks and Clinical Decision-MakingNew York, NY, United States 2009Introduction to Ethical Frameworks and Clinical Decision-Making
- Climate Change, Public Health and Emergency Preparedness,New York, NY, United States 2009Climate Change, Public Health and Emergency Preparedness,
- Biotechnology in 20 Years: Privatization and Ethical ConsiderationsNew York, NY, United States 2008Biotechnology in 20 Years: Privatization and Ethical Considerations
- Balancing Autonomy and Community in Promotion of Human DignityNew York, NY, United States 2008Balancing Autonomy and Community in Promotion of Human Dignity
- New Dilemmas in Modern MedicineNew York, NY, United States 2008New Dilemmas in Modern Medicine
- Ethics of Pandemic Decision-making and Allocation of Medical ResourcesErie, PA, United States 2008Ethics of Pandemic Decision-making and Allocation of Medical Resources
- Ethical Frameworks and Disaster PreparednessErie, PA, United States 2008Ethical Frameworks and Disaster Preparedness
- New Ethical Dilemmas in MedicineNew York, NY, United States 2008New Ethical Dilemmas in Medicine
- Bioethical Frameworks and Pandemic PreparednessNew York, NY, United States 2007Bioethical Frameworks and Pandemic Preparedness
- Did I Hasten My Patient’s Death?Bridgeport, CT, United States 2007Did I Hasten My Patient’s Death?
- LectureBridgeport, CT, United States 2007-
- LectureBridgeport, CT, United States 2007Lecture
- Grand Rounds LectureBridgeport, CT, United States 2007Grand Rounds Lecture
- Ethics of Adoption and Freezing of Embryos and Natural LawNew York, NY, United States 2005Ethics of Adoption and Freezing of Embryos and Natural Law
- Stem Cell Research Ethics, Course Lecture for Philosophical EthicsNew York, NY, United States 2002Stem Cell Research Ethics, Course Lecture for Philosophical Ethics
Honors & Recognition
| Award | Awarding Organization | Date |
|---|---|---|
| Center for the Fourth Industrial Revolution, Precision Medicine Council | Appointment to World Economic Forum | 2019 |
| Biotechnology Council | Appointment to World Economic Forum | 2018 |
| Futures Council | Appointment to World Economic Forum | 2017 |
| Human Enhancement Working Group | Appointment to World Economic Forum | 2017 |
| Ethical Issues in Global Population Health, Foundation Brocher | Fellow | 2014 |
| United Nations Educational Social and Cultural Organization (UNESCO) Global Ethics Observatory | Appointed | 2009 |
Professional Service
| Organization | Role | Date |
|---|---|---|
| Present Working Group Member, Consortia for Improving Medicine with Innovation and Technology (CIMIT), Yale University (NIH-funded U54 Coordinating Center, focused on point of care testing SARS-CoV-2) directed at Yale by Michael K. Dempsey & at Harvard by Steven Schachter | NIH-funded U54 Coordinating Center, focused on point of care testing SARS-CoV-2, national effort coordinated through NIH, directed at Yale by Michael K. Dempsey and at Harvard by Steven Schachter | 2020 |
| Yale Pediatric Nephrology Residents Research Ethics Lecture (March 27, 2020) | Lecturer | 2020 |
| Yale Data Day, Cushing Whitney Medical Library Class: "Data and Privacy: Day of Data Series Panel Discussion, Yale Medical School Library (February 13, 2020) | Participant | 2020 |
| Yale Center For Clinical Investigation (YCCI), NCATS Clinical Translational Science Award (CTSA), Mount Sinai Curriculum for Bioethics Training in Data Science and AI | Lead | 2020 - Present |
| Present Yale Equity Research and Innovation Center (ERIC), Covid Disparities Working Group | Member | 2020 - Present |
| Consortia for Improving Medicine with Innovation and Technology (CIMIT), NIH-funded U54 Coordinating Center | NIH-funded U54 Coordinating Center focused on point of care testing SARS-CoV-2, national effort coordinated through NIH, directed at Yale by Michael K. Dempsey and at Harvard by Steven Schachter | 2020 - Present |
| Alexion Pharmaceuticals Ethics Committee, Expanded Access Program for Covid-Related Drugs and ALS Program | Committee Member | 2020 - Present |
| Scientific American, Science for Good | Editor | 2020 - Present |
| Expanded Access Program for Covid-Related Drugs and ALS Program, Ethics Committee, Alexion Pharmaceuticals | Committee Member | 2020 - Present |
| Committee on Standards for Data Collection and Use, IEEE | Advisor | 2019 - 2020 |
| Yale Law School Health Data Workshop Co-Chair with Chris Morten, Joe Ross, Jen Pinsoff, Amy Kapczynski | Co-Chair | 2019 |
| Yale Digital Medicine Symposium, Ethical Considerations in Digital Medicine, April 26, 2019 | Presenter/Speaker | 2019 |
| Nature Medicine | Reviewer | 2019 - Present |
| BMC Medicine | Reviewer | 2019 - Present |
| The Journal of Bioethics | Reviewer | 2019 - Present |
| Yale Law School, Center for Research and Integrity | Member | 2018 - 2019 |
| Yale Law School MFIA Clinic, Data-Sharing in Medicine, Supervisor | Lead | 2018 - 2019 |
| Director’s Working Group on Ethical Considerations for Industry Partnership on Research to Help End the Opioid Crisis, NIH | Committee Member | 2018 |
| New England Journal of Medicine (NEJM) | Reviewer | 2018 - Present |
| The British Medical Journal (BMJ) | Reviewer | 2018 - Present |
| World Economic Forum | Member | 2017 - Present |
| New York University (NYU) School of Medicine, Pharmacy and Therapeutics Committee | Committee Member | 2016 - 2019 |
| The Journal of the American Medical Association (JAMA) Internal Medicine | Reviewer | 2016 - Present |
| Pharmacy and Therapeutics Committee, NYU School of Medicine | Committee Member | 2016 - Present |
| NYU Electronic Medical Records (EMR) Working Group, New York University | Tasked with developing new guidelines for incorporating clinical research into Epic | 2016 - Present |
| Institutional Review Board, Embryonic Stem Cell Research Oversight, New York University (NYU) School of Medicine | Committee Member | 2015 - 2019 |
| Compassionate Use and Expanded Access Committee, Johnson and Johnson (J&J) and New NYU School of Medicine | Scientific Advisor | 2015 - 2017 |
| Journal of Evidence-based Medicine & Public Health | Editor | 2015 - 2016 |
| Committee on Data Sharing and Transparency, Harvard University Multi-Regional Clinical Trials Initiative | Board Member | 2015 - 2016 |
| Advanced Disaster Life Support (ADLS®) | Ethical and Legal Considerations (Chapter 5), Advanced Disaster Life Support (ADLS®) Course Manual, Version 3.0, American Medical Association (Miller, J. Advisor and Reviewer) | 2015 |
| Core Disaster Life Support (CDLS®) | Legal and Ethical Issues (Chapter 5), Core Disaster Life Support (CDLS®) Course Manual, Version 3.0, American Medical Association (Miller, J. Advisor and Reviewer) | 2015 |
| Journal of Clinical Pharmacology | Reviewer | 2015 - Present |
| Stem Cells Translation Medicine | Reviewer | 2015 - Present |
| Embryonic Stem Cell Research Oversight Committee, NYU School of Medicine | Committee Member | 2015 - Present |
| Pragmatic Clinical Trials Initiative, Gatekeepers Workgroup, PCORI-NIH Collaboratory and National Patient-Centered Clinical Research Network | Board Member | 2014 - 2015 |
| Pragmatic Clinical Trials Initiative, Vulnerable Subjects Workgroup, PCORI-NIH Collaboratory and National Patient-Centered Clinical Research Network | Board Member | 2014 - 2015 |
| Public Library of Science (PLOS ONE) | Reviewer | 2014 - Present |
| Criteria for Data Sharing Subgroup, Harvard University Multi-Regional Clinical Trials Initiative | Co-Chair | 2013 - 2014 |
| Pharmaceutical Regulatory Affairs: Open Access, OMICS Publishing Group | Reviewer | 2013 - Present |
| Law and Society Association, Institutional Corruption | Committee Member | 2012 - 2015 |
| Ethics Committee, Harvard University Multi-Regional Clinical Trials Initiative | Committee Member | 2012 - 2014 |
| American Society of Bioethics and Humanities | Member | 2012 - Present |
| Center for Policy and Emerging Technologies, Advisory Board | Board Member | 2010 - 2015 |
| Center for Policy and Emerging Technologies, Center for Policy and Emerging Technologies | Advisor | 2010 - 2015 |
| Advisory Board, Center for Policy and Emerging Technologies | Advisor | 2010 - 2015 |
| Ethics Committee and IRB Workshop Director, Tampa General Hospital, Morsani College of Medicine, University of South Florida | Director | 2010 |
| Pediatric Emergency Mass Critical Care Taskforce, Steering Committee, Centers for Disease Control and Prevention (CDC) | Committee Member | 2009 - 2011 |
| Pediatric Emergency Mass Critical Care Taskforce, Ethics Committee, Centers for Disease Control and Prevention (CDC) | Committee Member | 2009 - 2011 |
| Pandemic and Emergency Preparedness Ethics Grand Rounds Director, St. Vincent’s Health System (Pennsylvania) | Director | 2008 |
| Pandemic and Emergency Preparedness Ethics Grand Rounds Director for the Department of Emergency Medicine, Hamot Hospital (Pennsylvania) | Director | 2008 |
| American Medical Association, National Disaster Life Support Education Consortium | Member | 2007 - 2011 |
| American Museum of Natural History, Junior Advisory Council | Council Member | 2007 - 2011 |
| ICU Rounds on End of Life Care Ethics, St. Vincent’s Medical Center (Connecticut) | Lecturer | 2007 |
| Medical Ethics Lecturer for Radiology and Transitional Year Residency Program, St. Vincent’s Medical Center (Connecticut) | Lecturer | 2007 |
| Medical Ethics Lecturer for Internal Medicine Department, St. Vincent’s Medical Center (Connecticut) | Lecturer | 2007 |
| Pandemic and Emergency Preparedness Ethics Hospital-Wide Grand Rounds, St. Vincent’s Medical Center (Connecticut) | Lecturer | 2007 |
| Bioethics International | President | 2006 - Present |
| Bioethics International | Board Member | 2005 - Present |
| Bellevue Hospital, High School Pediatric Psychiatric Ward Volunteers, Volunteer Director | Director | 2004 - 2006 |
Departments & Organizations
- Biomedical Informatics & Data Science
- Collaboration for Regulatory Rigor, Integrity, and Transparency (CRRIT)
- General Internal Medicine
- Internal Medicine
- Program for Biomedical Ethics
- Yale Center for Genomic Health